Literature DB >> 16626345

Benefits of early aggressive management of empyema thoracis.

Mehmet Bilgin1, Yigit Akcali, Fahri Oguzkaya.   

Abstract

BACKGROUND: The end-target of the management of thoracic empyema is to obtain early rehabilitation by re-expansion of the trapped lung resulting from intrapleural infected material. Our aim was to shorten the hospitalization time and to prevent a possible thoracotomy by using video-assisted thoracoscopy initially.
METHODS: Seventy patients with parapneumonic empyema were prospectively studied between January 1997 and June 2004. The patients were randomly divided into two groups. In group I (n = 35 patients), a chest tube was inserted into the patients after pleural content was evacuated and fibrins were debrided using video-assisted thoracoscopy. In group II (n = 35 patients), tube thoracostomy was carried out without using a video-assisted thoracoscope. Both groups were compared in terms of hospitalization time, open surgery for decortication and complications.
RESULTS: There was no statistically significant difference between the groups from the point of view of age and sex (P > 0.05). In group I, 17.1% of the patients underwent open decortication, whereas in group II, 37.1% of the patients underwent the same procedure (P < 0.05). Whereas average hospital stay in group I was 8.3 days (range, 7-11 days), it was 12.8 days in group II (range, 10-18 days; P < 0.05). There was one bronchopleural fistula in group I, and there was one bronchopleural fistula and one death in group II.
CONCLUSION: Video-assisted thoracoscopic evacuation and chest tube insertion in situ is a new therapeutic approach for pleural empyema that shortens hospital stay and reduces the necessity of open decortication.

Entities:  

Mesh:

Year:  2006        PMID: 16626345     DOI: 10.1111/j.1445-2197.2006.03666.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  21 in total

1.  Counterpoint: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? No.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

2.  Rebuttal from Drs Colice and Idell.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

3.  Therapeutic strategy for acute pleural empyema: comparison between retrospective study and prospective study.

Authors:  Hitoshi Suzuki; Shin Shomura; Yasuhiro Sawada; Akira Shimamoto; Chiaki Kondo; Motoshi Takao; Hideto Shimpo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-05-03

4.  Timely thoracoscopic decortication promotes the recovery of paediatric parapneumonic empyema.

Authors:  C T Lau; C H Fung; K K Y Wong; P Tam
Journal:  Pediatr Surg Int       Date:  2015-06-03       Impact factor: 1.827

5.  Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score.

Authors:  Sunkaru Touray; Rahul N Sood; Daniel Lindstrom; Jonathan Holdorf; Sumera Ahmad; Daniel B Knox; Andres F Sosa
Journal:  Lung       Date:  2018-08-11       Impact factor: 2.584

6.  Assessment of the usefulness of video-assisted thoracoscopic surgery in patients with non-tuberculous thoracic empyema.

Authors:  Heesung Lee; Sangmyeon Park; Hoseung Shin; Kunil Kim
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 7.  Infectious pleural effusion status and treatment progress.

Authors:  Wei Yang; Bo Zhang; Ze-Ming Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

8.  Pleural infection-current diagnosis and management.

Authors:  Andrew Rosenstengel
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

9.  Complicated parapneumonic effusion and empyema: pleural decortication and video-assisted thoracic surgery.

Authors:  Shi-Ping Luh; Gwo-Jong Hsu; Chen Cheng-Ren
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 10.  VATS and open chest surgery in diagnosis and treatment of benign pleural diseases.

Authors:  Periklis Perikleous; Sridhar Rathinam; David A Waller
Journal:  J Vis Surg       Date:  2017-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.